2021 annual financial data
Theravance Biopharma 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -375.8%.
Operating income was -257,784,000 USD and net income was -199,426,000 USD.
Operating cash flow was -207,858,000 USD.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 55,311,000 USD
- Operating income
- -257,784,000 USD
- Net income
- -199,426,000 USD
- Operating cash flow
- -207,858,000 USD